Skip to main content

HIV/AIDS Topic Center

Interactive Features

research review


Research Review
10/14/2024
Hannah Musick
Research presented at AMCP Nexus 2024 suggests that switching to long-acting antiretroviral therapy (ART) may significantly improve adherence and persistence in people with HIV (PWH) compared to staying on traditional oral ART, offering a...
Research presented at AMCP Nexus 2024 suggests that switching to long-acting antiretroviral therapy (ART) may significantly improve adherence and persistence in people with HIV (PWH) compared to staying on traditional oral ART, offering a...
Research presented at AMCP Nexus...
10/14/2024
First Report Managed Care
Research Review
01/12/2024
Hannah Musick
In this research review, long-acting injectable regimen cabotegravir + rilpivirine (CAB+RPV LA) and daily bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) treatment regimens for patients with HIV are compared in terms of...
In this research review, long-acting injectable regimen cabotegravir + rilpivirine (CAB+RPV LA) and daily bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) treatment regimens for patients with HIV are compared in terms of...
In this research review,...
01/12/2024
First Report Managed Care